Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings

• Andrew Phillips ,

  * E-mail: andrew.phillips@ucl.ac.uk

  Affiliation Research Department of Infection & Population Health, UCL, London, United Kingdom

  ⨯
• Valentina Cambiano,

  Affiliation Research Department of Infection & Population Health, UCL, London, United Kingdom

  ⨯
• Fumiyo Nakagawa,

  Affiliation Research Department of Infection & Population Health, UCL, London, United Kingdom

  ⨯
• Travor Magubu,

  Affiliation University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe

  ⨯
• Alec Miners,

  Affiliation Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯
• Debbie Ford,

  Affiliation MRC Clinical Trials Unit, UCL, London, United Kingdom

  ⨯
• Deenan Pillay,

  Affiliation Africa Centre, KwaZulu Natal, South Africa

  ⨯
• Andrea De Luca,

  Affiliation University Division of Infectious Diseases, Siena University Hospital, Siena, Italy

  ⨯
• Jens Lundgren,

  Affiliation Dept of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Paul Revill

  Affiliation Centre for Health Economics, University of York, York, United Kingdom

  ⨯